Scores of promising technologies that have been spun out of a university wind up gathering dust, once they’ve been licensed by a pharmaceutical company.
That’s because tech transfer offices often license out technology when it’s still very early stage — and drug makers at times give up trying to validate them.
About the Author Reprints
